查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1828131

2025年全球植入式心律管理設備市場報告

Implantable Cardiac Rhythm Management Device Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，植入式心律管理設備市場穩定成長，市場規模從2024年的170.6億美元成長至2025年的177億美元，複合年成長率為3.8%。預測期內的成長歸因於人口老化、心律不整發病率上升、意識提升和教育措施的推進、醫療基礎設施的建設以及醫療支出的增加。

預計未來幾年植入式心律管理設備市場將強勁成長，2029年將達到231.5億美元，複合年成長率為6.9%。預測期內的成長可歸因於向無導線設備的轉變、遠端病患監測、對心臟衰竭管理的日益重視、新興市場的日益普及以及研發合作。預測期內的主要趨勢包括生物可吸收技術的興起、人工智慧 (AI) 的整合、技術進步、遠端監測與遠端醫療的整合、無導線心律調節器的進步、無線充電和電源管理。

植入式心律管理裝置是一種小型、電池供電的裝置，透過手術植入體內並連接到心臟，在維持和管理心律方面發揮重要作用。

植入式心律管理設備類別的主要設備包括心臟再同步治療 (CRT)、去心房顫動和心律調節器。心臟再同步治療 (CRT) 是一種專門針對嚴重心律問題的治療方法。這些設備在醫院、心臟中心和其他醫療機構中用於治療各種疾病，包括心搏過緩心搏過速。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制價格上漲，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、加強標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司（The Business Research Company）新報告系列的一部分，該系列提供植入式心律管理設備市場統計數據，例如全球市場規模、區域佔有率、競爭對手的市場佔有率、詳細的植入式心律管理設備細分市場、市場趨勢和商業機會，為您提供在植入式心律管理設備行業取得成功所需的數據。本植入式心律管理設備市場研究報告提供了您所需的所有資訊，並詳細分析了該行業的現狀和未來情況。

我們預測未來五年該市場將成長6.9%，較先前預測略有下降0.1%。這一下降主要源自於美國與其他國家之間關稅的影響。這可能會對美國造成直接影響，例如對來自墨西哥和丹麥等主要地區的長壽命鋰電池和生物相容性鉛絕緣材料徵收關稅，從而可能導致心律調節器/去心房顫動植入推遲，並增加心臟護理成本。此外，由於貿易緊張局勢加劇和限制措施增加，互惠關稅以及對全球經濟和貿易的負面影響，這種影響也將更為廣泛地顯現。

心臟病患病率的上升預計將顯著推動植入式心律管理設備市場的成長。心臟病是指影響心臟和血管的疾病。植入式心律管理設備旨在透過心臟再同步改善收縮功能並在危及生命的快速心室心律不整期間恢復正常心律，從而幫助心臟衰竭或左心室功能減退的患者。因此，心臟病盛行率的上升將推動對這些設備的需求。例如，英國心血管研究慈善機構英國心臟基金會的數據顯示，截至2024年9月，英國約有760萬人患有心臟和循環系統疾病。其中，約有400萬男性和360萬名女性患有這些疾病，約佔英國所有死亡人數的27%，每年超過17萬人死亡。因此，心臟病盛行率的上升是推動植入式心律管理設備市場成長的關鍵因素。

預計未來幾年，老齡化人口的成長將顯著推動植入式心律管理設備市場的成長。老化是指人口中很大一部分正在老化，並且人口平均年齡不斷增加的人口群體。植入式心律管理設備經常被這類人群用於解決和管理各種心臟相關問題。例如，2024 年 1 月，美國非營利組織人口問題實驗室預測，65 歲及以上的美國數量將從 2022 年的 5,800 萬人增加 47% 到 2050 年的 8,200 萬人。此外，預計同期該年齡層在總人口中的比例將從 17% 增加到 23%。因此，老化人口的擴大是推動植入式心律管理設備市場成長的主要因素。

技術進步是植入式心律管理設備市場的一大趨勢，主要企業專注於開發創新技術以維持其市場地位。美國公司 Rhythm Management Group PLLC 於 2022 年 4 月宣布推出 RhythmSynergy。 RhythmSynergy 是一個技術平台，利用機器學習為使用植入式心臟設備和穿戴式裝置進行遠端監控的患者提供及時的臨床洞察。該平台透過將臨床知識與機器學習技術相結合，簡化了審查流程，使患者數據的審查、共用和分析變得更加簡單。

植入式心律管理設備市場的主要企業正優先推出創新產品，例如植入式心臟去心房顫動。 2023年10月，法國製造商MicroPort CRM推出了ULYS植入式心臟整流去顫器（ICD）和INVICTA去心房顫動植入式設備。 ULYS ICD整合了最尖端科技、AutoMRI功能和PARAD心律不整辨識演算法，最大限度地降低了功耗。 INVICTA去心房顫動導線持續偵測來自右心室的電訊號，並在心率過低時進行心律調節治療。

2022年8月，美國醫療科技公司Medtronic完成了對Affera的收購，收購金額未揭露。此次收購使Medtronic能夠使用Affera Prism-1TM心臟定位和導航平台，該平台支援Medtronic的治療導管和一系列競爭技術。 Affera是一家總部位於美國的醫療科技公司，專門生產用於治療心律不整患者的心臟定位和導航系統。

植入式心律管理設備市場的主要企業包括 Schiller AG、Medtronic plc、Abbott Laboratories、Boston Scientific Corporation、Koninklijke Philips NV、Zoll Medical Corporation、BIoTronik Ltd.、MicroPort Scientific Corporation、Abiomed Inc.、Nihon Kohden Corporation、Japan Lifeline Co. Ltd.、Lepu Medical Technology Co. Ltd.、LivaNova PLC、深圳邁瑞生物醫學電子股份有限公司、Progetti Srl、Edwards Lifesciences Corporation、Cardiac Science Corporation、Bardy Diagnostics Inc.、北京迪瑪克醫療技術有限公司、iRhythm Technologies Inc.、Impulse Dynamics plc. 和 VytronUS Inc.。

2024 年，北美是植入式心律管理設備市場最大的地區。植入式心律管理設備市場報告涵蓋的地區包括亞太地區、西歐、東歐、北美、南美、中東和非洲。

植入式心律管理設備市場報告涵蓋的國家：澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國、美國、加拿大、義大利、西班牙

植入式心律管理設備市場涵蓋無導線心律調節器、植入式心臟監視器、心臟導線以及植入式心臟整流去顫器(S-ICD) 的銷售。此市場的價值是指“出廠價”，即商品製造商或生產商向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的商品價值。該市場中的商品價值還包括商品製造商提供的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球植入式心律管理設備：PESTEL分析（政治、社會、科技、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球植入式心律管理設備市場：成長率分析
  • 全球植入式心律管理設備市場表現：規模與成長，2019-2024
  • 全球植入式心律管理設備市場預測：規模與成長，2024-2029年，2034年
  • 全球植入式心律管理設備：總目標市場（TAM）

第6章 市場細分

  • 全球植入式心律管理設備市場（按設備、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 心臟再同步治療（CRT）
  • 去心房顫動
  • 心律調節器
  • 全球植入式心律管理設備市場應用、效能及預測（2019-2024、2024-2029、2034）
  • 心搏過緩
  • 心搏過速
  • 其他
  • 全球植入式心律管理設備市場（依最終用途、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 專門的心臟中心
  • 其他
  • 全球植入式心律管理設備市場：心臟再同步治療 (CRT) 細分市場、類型、績效及預測（2019-2024 年、2024-2029 年、2034 年）
  • CRT-P（心律調節器）
  • CRT-D（去心房顫動）
  • 全球植入式心律管理設備市場：去心房顫動細分、類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 植入式心臟整流去顫器（ICD）
  • 皮下植入式心臟整流去顫器（S-ICD）
  • 全球植入式心律管理設備市場：心律調節器細分市場，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 單腔心律調節器
  • 雙腔心律調節器
  • 雙心室節律器

第7章 區域和國家分析

  • 全球植入式心律管理設備市場：2019-2024 年、2024-2029 年及 2034 年區域表現與預測
  • 全球植入式心律管理設備市場：國家、績效及預測（2019-2024、2024-2029、2034）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 植入式心律管理設備市場：競爭格局
  • 植入式心律管理設備市場：公司簡介
    • Schiller AG
    • Medtronic plc
    • Abbott Laboratories
    • Boston Scientific Corporation
    • Koninklijke Philips NV

第31章：其他領先和創新企業

  • Zoll Medical Corporation
  • BIoTronik Ltd.
  • MicroPort Scientific Corporation
  • Abiomed Inc
  • Nihon Kohden Corporation
  • Japan Lifeline Co. Ltd.
  • Lepu Medical Technology Co. Ltd.
  • LivaNova PLC
  • Shenzhen Mindray Biomedical Electronics Co. Ltd
  • Progetti Srl
  • Edwards Lifesciences Corporation
  • Cardiac Science Corporation
  • Bardy Diagnostics Inc.
  • Beijing Demax Medical Technology Co. Ltd
  • iRhythm Technologies Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第35章：市場潛力大的國家與策略

  • 2029年植入式心律管理設備市場：提供新機會的國家
  • 2029年植入式心律管理設備市場：細分市場將帶來新機會
  • 2029年植入式心律管理設備市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r24222u

Implantable cardiac rhythm management devices are small battery-operated devices that are surgically inserted inside the body and connected to the heart, playing a crucial role in maintaining and managing heart rhythm.

The primary devices in the category of implantable cardiac rhythm management devices include cardiac resynchronization therapy, defibrillators, and pacemakers. Cardiac resynchronization therapy (CRT) is a specialized treatment designed for severe cardiac rhythm issues. These devices find applications in various conditions such as bradycardia, tachycardia, and others, and are utilized in hospitals, specialty cardiac centers, and other medical settings.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The implantable cardiac rhythm management device market research report is one of a series of new reports from The Business Research Company that provides implantable cardiac rhythm management device market statistics, including implantable cardiac rhythm management device industry global market size, regional shares, competitors with implantable cardiac rhythm management device market share, detailed implantable cardiac rhythm management device market segments, market trends, and opportunities, and any further data you may need to thrive in the implantable cardiac rhythm management device industry. This implantable cardiac rhythm management device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The implantable cardiac rhythm management device market size has grown steadily in recent years. It will grow from $17.06 billion in 2024 to $17.7 billion in 2025 at a compound annual growth rate (CAGR) of 3.8%. The growth in the historic period can be attributed to the aging population, increasing incidence of cardiac arrhythmias, awareness and education initiatives, healthcare infrastructure development, and rising healthcare expenditure.

The implantable cardiac rhythm management device market size is expected to see strong growth in the next few years. It will grow to $23.15 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to a shift towards leadless devices, remote patient monitoring, a focus on heart failure management, increased adoption in emerging markets, and collaborations for research and development. Major trends in the forecast period include the emergence of bioresorbable technologies, integration of artificial intelligence (AI), advancements in technology, remote monitoring and telemedicine integration, advancements in leadless pacemakers, wireless charging, and power management.

The forecast of 6.9% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on long-life lithium batteries and biocompatible lead insulation materials, sourced from key regions such as Mexico and Denmark, which could lead to postponed pacemaker/defibrillator implants and higher costs for cardiac care.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising incidence of cardiac disorders is anticipated to significantly enhance the growth of the implantable cardiac rhythm management devices market. Cardiac disorders refer to conditions that impact the heart or blood vessels. Implantable cardiac rhythm management devices are designed to assist patients with heart failure and diminished left ventricular function by improving systolic function through the resynchronization of heart contractions and restoring normal rhythm during life-threatening rapid ventricular arrhythmias. As a result, the growing prevalence of cardiac disorders will drive demand for these devices. For instance, in September 2024, data from the British Heart Foundation, a UK-based cardiovascular research charity, revealed that approximately 7.6 million individuals in the UK are affected by heart and circulatory diseases. This includes about 4 million men and 3.6 million women living with these conditions, which account for roughly 27% of all deaths in the UK, translating to over 170,000 fatalities each year, or about 480 deaths per day-equivalent to one death every three minutes. Therefore, the increasing prevalence of cardiac disorders is a key factor propelling the growth of the implantable cardiac rhythm management devices market.

The growing aging population is anticipated to significantly drive the growth of the implantable cardiac rhythm management devices market in the coming years. An aging population refers to a demographic trend where a significant portion of a country's citizens are becoming older, leading to a higher average age among its residents. Implantable cardiac rhythm management devices are frequently utilized within this demographic to address and manage various heart-related issues. For example, in January 2024, the Population Reference Bureau, a US-based nonprofit organization, projected that the number of Americans aged 65 and older will rise from 58 million in 2022 to 82 million by 2050, marking a 47% increase. Additionally, this age group's proportion of the total population is expected to increase from 17% to 23% over the same period. Consequently, the expanding aging population is a key factor propelling the growth of the implantable cardiac rhythm management devices market.

Technological advancement stands out as a prominent trend in the implantable cardiac rhythm management devices market, with major companies focusing on developing innovative technologies to maintain their market position. Rhythm Management Group PLLC, a US-based company, introduced RhythmSynergy in April 2022, a technology platform that utilizes machine learning to deliver timely clinical insights for patients monitored remotely with implantable cardiac devices and wearable devices. This platform streamlines the review processes by combining clinical knowledge and machine learning technologies, making it simpler to review, share, and analyze patient data.

Major companies in the implantable cardiac rhythm management devices market prioritize the launch of innovative products such as implantable cardiac defibrillators. In October 2023, MicroPort CRM, a France-based manufacturer, launched the ULYS Implantable Cardioverter Defibrillator (ICDs) and INVICTA defibrillation implantable devices. The ULYS ICD integrates cutting-edge technology with minimal energy consumption, featuring the AutoMRI function and PARAD arrhythmia discrimination algorithm. The INVICTA defibrillation lead consistently senses electrical signals from the right ventricle, providing pacing therapy if the heart rate is too low.

In August 2022, Medtronic, a US-based medical technology company, completed the acquisition of Affera Inc. for an undisclosed amount. This acquisition grants Medtronic access to the Affera Prism-1TM cardiac mapping and navigation platform, compatible with both Medtronic therapeutic catheters and various competing technologies. Affera Inc., a US-based medical technology company, specializes in manufacturing cardiac mapping and navigation systems for treating patients with cardiac arrhythmias.

Major companies operating in the implantable cardiac rhythm management device market include Schiller AG, Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Koninklijke Philips N.V., Zoll Medical Corporation, Biotronik Ltd., MicroPort Scientific Corporation, Abiomed Inc, Nihon Kohden Corporation, Japan Lifeline Co. Ltd., Lepu Medical Technology Co. Ltd., LivaNova PLC, Shenzhen Mindray Biomedical Electronics Co. Ltd, Progetti Srl, Edwards Lifesciences Corporation, Cardiac Science Corporation, Bardy Diagnostics Inc., Beijing Demax Medical Technology Co. Ltd, iRhythm Technologies Inc., Impulse Dynamics plc., VytronUS Inc.

North America was the largest region in the implantable cardiac rhythm management device market in 2024. The regions covered in the implantable cardiac rhythm management device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the implantable cardiac rhythm management device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The implantable cardiac rhythm management devices market consists of sales of the leadless pacemaker, insertable cardiac monitor, cardiac leads, and subcutaneous implantable defibrillator (S-ICD). Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Implantable Cardiac Rhythm Management Device Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on implantable cardiac rhythm management device market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for implantable cardiac rhythm management device ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The implantable cardiac rhythm management device market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Device: Cardiac Resynchronization Therapy; Defibrillators; Pacemakers
  • 2) By Application: Bradycardia; Tachycardia; Other Applications
  • 3) By End-Use: Hospitals; Specialty Cardiac Centers; Other End-Uses
  • Subsegments:
  • 1) By Cardiac Resynchronization Therapy (CRT): CRT-P (Pacemaker); CRT-D (Defibrillator)
  • 2) By Defibrillators: Implantable Cardioverter Defibrillators (ICDs); Subcutaneous Implantable Defibrillators (S-ICDs)
  • 3) By Pacemakers: Single-Chamber Pacemakers; Dual-Chamber Pacemakers; Biventricular Pacemakers
  • Companies Mentioned: Schiller AG; Medtronic plc; Abbott Laboratories; Boston Scientific Corporation; Koninklijke Philips N.V.; Zoll Medical Corporation; Biotronik Ltd.; MicroPort Scientific Corporation; Abiomed Inc; Nihon Kohden Corporation; Japan Lifeline Co. Ltd.; Lepu Medical Technology Co. Ltd.; LivaNova PLC; Shenzhen Mindray Biomedical Electronics Co. Ltd; Progetti Srl; Edwards Lifesciences Corporation; Cardiac Science Corporation; Bardy Diagnostics Inc.; Beijing Demax Medical Technology Co. Ltd; iRhythm Technologies Inc.; Impulse Dynamics plc.; VytronUS Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Implantable Cardiac Rhythm Management Device Market Characteristics

3. Implantable Cardiac Rhythm Management Device Market Trends And Strategies

4. Implantable Cardiac Rhythm Management Device Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Implantable Cardiac Rhythm Management Device Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Implantable Cardiac Rhythm Management Device PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Implantable Cardiac Rhythm Management Device Market Growth Rate Analysis
  • 5.4. Global Implantable Cardiac Rhythm Management Device Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Implantable Cardiac Rhythm Management Device Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Implantable Cardiac Rhythm Management Device Total Addressable Market (TAM)

6. Implantable Cardiac Rhythm Management Device Market Segmentation

  • 6.1. Global Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiac Resynchronization Therapy
  • Defibrillators
  • Pacemakers
  • 6.2. Global Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bradycardia
  • Tachycardia
  • Other Applications
  • 6.3. Global Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Specialty Cardiac Centers
  • Other End-Uses
  • 6.4. Global Implantable Cardiac Rhythm Management Device Market, Sub-Segmentation Of Cardiac Resynchronization Therapy (CRT), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • CRT-P (Pacemaker)
  • CRT-D (Defibrillator)
  • 6.5. Global Implantable Cardiac Rhythm Management Device Market, Sub-Segmentation Of Defibrillators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Implantable Cardioverter Defibrillators (ICDs)
  • Subcutaneous Implantable Defibrillators (S-ICDs)
  • 6.6. Global Implantable Cardiac Rhythm Management Device Market, Sub-Segmentation Of Pacemakers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Chamber Pacemakers
  • Dual-Chamber Pacemakers
  • Biventricular Pacemakers

7. Implantable Cardiac Rhythm Management Device Market Regional And Country Analysis

  • 7.1. Global Implantable Cardiac Rhythm Management Device Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Implantable Cardiac Rhythm Management Device Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Implantable Cardiac Rhythm Management Device Market

  • 8.1. Asia-Pacific Implantable Cardiac Rhythm Management Device Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Implantable Cardiac Rhythm Management Device Market

  • 9.1. China Implantable Cardiac Rhythm Management Device Market Overview
  • 9.2. China Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Implantable Cardiac Rhythm Management Device Market

  • 10.1. India Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Implantable Cardiac Rhythm Management Device Market

  • 11.1. Japan Implantable Cardiac Rhythm Management Device Market Overview
  • 11.2. Japan Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Implantable Cardiac Rhythm Management Device Market

  • 12.1. Australia Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Implantable Cardiac Rhythm Management Device Market

  • 13.1. Indonesia Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Implantable Cardiac Rhythm Management Device Market

  • 14.1. South Korea Implantable Cardiac Rhythm Management Device Market Overview
  • 14.2. South Korea Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Implantable Cardiac Rhythm Management Device Market

  • 15.1. Western Europe Implantable Cardiac Rhythm Management Device Market Overview
  • 15.2. Western Europe Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Implantable Cardiac Rhythm Management Device Market

  • 16.1. UK Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Implantable Cardiac Rhythm Management Device Market

  • 17.1. Germany Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Implantable Cardiac Rhythm Management Device Market

  • 18.1. France Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Implantable Cardiac Rhythm Management Device Market

  • 19.1. Italy Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Implantable Cardiac Rhythm Management Device Market

  • 20.1. Spain Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Implantable Cardiac Rhythm Management Device Market

  • 21.1. Eastern Europe Implantable Cardiac Rhythm Management Device Market Overview
  • 21.2. Eastern Europe Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Implantable Cardiac Rhythm Management Device Market

  • 22.1. Russia Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Implantable Cardiac Rhythm Management Device Market

  • 23.1. North America Implantable Cardiac Rhythm Management Device Market Overview
  • 23.2. North America Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Implantable Cardiac Rhythm Management Device Market

  • 24.1. USA Implantable Cardiac Rhythm Management Device Market Overview
  • 24.2. USA Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Implantable Cardiac Rhythm Management Device Market

  • 25.1. Canada Implantable Cardiac Rhythm Management Device Market Overview
  • 25.2. Canada Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Implantable Cardiac Rhythm Management Device Market

  • 26.1. South America Implantable Cardiac Rhythm Management Device Market Overview
  • 26.2. South America Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Implantable Cardiac Rhythm Management Device Market

  • 27.1. Brazil Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Implantable Cardiac Rhythm Management Device Market

  • 28.1. Middle East Implantable Cardiac Rhythm Management Device Market Overview
  • 28.2. Middle East Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Implantable Cardiac Rhythm Management Device Market

  • 29.1. Africa Implantable Cardiac Rhythm Management Device Market Overview
  • 29.2. Africa Implantable Cardiac Rhythm Management Device Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Implantable Cardiac Rhythm Management Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Implantable Cardiac Rhythm Management Device Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Implantable Cardiac Rhythm Management Device Market Competitive Landscape And Company Profiles

  • 30.1. Implantable Cardiac Rhythm Management Device Market Competitive Landscape
  • 30.2. Implantable Cardiac Rhythm Management Device Market Company Profiles
    • 30.2.1. Schiller AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis

31. Implantable Cardiac Rhythm Management Device Market Other Major And Innovative Companies

  • 31.1. Zoll Medical Corporation
  • 31.2. Biotronik Ltd.
  • 31.3. MicroPort Scientific Corporation
  • 31.4. Abiomed Inc
  • 31.5. Nihon Kohden Corporation
  • 31.6. Japan Lifeline Co. Ltd.
  • 31.7. Lepu Medical Technology Co. Ltd.
  • 31.8. LivaNova PLC
  • 31.9. Shenzhen Mindray Biomedical Electronics Co. Ltd
  • 31.10. Progetti Srl
  • 31.11. Edwards Lifesciences Corporation
  • 31.12. Cardiac Science Corporation
  • 31.13. Bardy Diagnostics Inc.
  • 31.14. Beijing Demax Medical Technology Co. Ltd
  • 31.15. iRhythm Technologies Inc.

32. Global Implantable Cardiac Rhythm Management Device Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Implantable Cardiac Rhythm Management Device Market

34. Recent Developments In The Implantable Cardiac Rhythm Management Device Market

35. Implantable Cardiac Rhythm Management Device Market High Potential Countries, Segments and Strategies

  • 35.1 Implantable Cardiac Rhythm Management Device Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Implantable Cardiac Rhythm Management Device Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Implantable Cardiac Rhythm Management Device Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer